chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up with hives 12/30. Took Benadryl, Claritin. No relief. Continued to worsen over weekend. Also onset of heartburn and esophageal spasms. Received medrol dose pack and protonix Monday, January 3.
Information has been received from a physician concerning a patient who on 31-JUL-2008 was vaccinated with their first dose of oral ROTATEQ vaccine live (human-bovine), 2 ml, at 24 weeks of age. No averse effect reported. No product quality complaint. Additional information has been requested.
"I received my first shot and had only a little arm discomfort. I received my second Moderna shot Friday (1/22) at 1:50 PM. Approximately 8 hours later I suddenly became very tired. I could barely manage to get out of bed at 2 PM on Saturday to take my temperature. My temperature was 102.3 (I?m normally around 97.4 per my morning COVID symptom checks 2x/week). I had aches, chills, joint pain, extreme fatigue, and injection site pain, redness and bruising. I was so out of it that I am not sure I would have been able to navigate taking a fever reducer, eating food, and other basics. My partner assisted me with these things. The first round of Tylenol on Sunday eventually got me to 99.5 or 8 or some such. I continued to take Tylenol throughout Saturday and Sunday. Sunday I woke feeling fatigued and out of it, but definitely on the mend. Sunday late afternoon/ early eve, even more like myself. Today (Monday 1/25) generally back to normal"
Dizziness, Fever, SkinRash, Diarrhea, NauseaVomiting, left arm painful hard to lift. rash on left arm Narrative:
Fever     102. ,  nauseas, shaking chills, acute head pain, and pain in legs and arms.  The day after the second dose of the vaccine
Breakthrough case admission after 3 vaccines: Moderna 1/26/21 Lot# 007M20A;  Moderna 2/26/21 Lot# 010A21A;  Moderna 11/1/21 Lot# 005C21A.
Within a day or so my right side of body went numb and I couldnt use phone.  My left foot burned, while my right foot was numb.  I had burning set in in the blood cessels in hands.  I ended up falling off my deck as well twisting ankle.  I ended up getting chest pain and tremors as well like a parkinson's patient.  I believe my covid hands and feet came back as well (toes change colors and hands had brown spots that I had with longhaul). The chest pain and tremors lasted a few weeks.  I had tremors from long covid that were under control prior to vacvine, but vaccine set them off and made me more food intolerant as well.  Was hard to sleep at night because of shaking.  The chest pain went away after a few weeks and tremors seemed to calm as time passed. (coming and going). The chest pain then came back after I went for a hike.  It lasted for a weeks and was off and on.  Then seemed to go away and come back.  Around Oct. 7, I had another bad episode of tremors and chest pain at same time and bad head pressure on top front left of head. like someone was sitting my head.  The week prior for some reason my foot had been black  (like bruised, worse than the covid toes I had had for close to a year or so off and on from long covid) and the covid toes came with the bruise like look on foot that covered half of right foot.
got very sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis and PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine, COVID-19 VACCINE and PNEUMONIA VACCINE. On an unknown date, an unknown time after receiving Shingles vaccine and an unknown time after receiving COVID-19 VACCINE, the patient experienced sickness (Verbatim: got very sick). The outcome of the sickness was not reported.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine.   Additional Information: Receipt date: 01-AUG-2023 This case was reported by patient via interactive digital media. The patient reported that he/she received the first dose of Shingles vaccine with the pneumonia and Covid-19 vaccines, he/she got very sick, with the second dose, he/she did not have any negative reactions. It was unknown if the reporter considered the sickness to be related to Covid-19 vaccine and Pneumonia vaccine.     Follow up was not possible, as no contact details were available.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unspecified age. Information about the patient's concurrent condition, concomitant medication or medical history was not provided. On or around 05-OCT-2015 the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (strength, dose, route, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date in 2015 (reported as shortly after the vaccination), the patient suffered a bad case of the shingles, a severe and permanent personal injury. As the result of vaccine live(ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. She also suffered medical expenses, the loss of accumulations and other economic and non-economic damages. The outcome of herpes zoster was not recovered/not resolved. The reporter considered herpes zoster to be disable and related to Zoster Vaccine Live(ZOSTAVAX).
receiving booster dose from an expired vial; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041c21a, 017821a, and 036a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED. On 12-Dec-2021, EXPIRED PRODUCT ADMINISTERED had resolved.            No concomitant medications was provided. No treatment medications was provided.   Most recent FOLLOW-UP information incorporated above includes on 22-Dec-2021 Follow up received.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 78 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "high bp" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course- The patient received vaccine and Other medication in 2weeks. The patient had no known allergy.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On Dec 29, 2021, I woke up feeling very ill. I was coughing hard (productive cough). I had fever (102F), headache, and sinus congestion. I was visiting family, arriving on 26 Dec. I got tested that day. on 31 Dec, I received a positive result for my COVID PCR test. I sought hospital treatment at an Emergency room when my O2 dropped to 89 but was turned away. My symptoms remained until 5 Jan 2022, when my congestion and fever abated. During that week, I self medicated with ibuprofen and acetaminophen, 2400 mg and 4000 mg respectively, daily. i used cough medicine and throat lozenges to treat cough symptoms. I used pseudoephedrine to treat congestion. My cough also changed to an uncontrollable dry cough in
This spontaneous report as received from a physician refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 03-MAY-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # L043213, expiration date 28-AUG-2017 (dose and route of administration were not reported). There was no adverse effect reported. No product quality issue was involved. Administered dose of vaccine experienced the temperature excursion of low -28 degrees Fahrenheit for 5 hours on 22-APR-2016. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT RECEIVED SECOND BOOSTER AND WAS NOT ELEGIBLE TO DO SO PER GUIDELINES.
Fever chills, body ache. right arm sore. headache. Narrative:  Patient had second dose of Moderna vaccine yesterday, and today presenting with following symptoms: chills, body ache. right arm sore. headache.
Since having my vaccine I have developed a horrible; Pregnant; This spontaneous retrospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and MALAISE (Since having my vaccine I have developed a horrible) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-May-2020 and the estimated date of delivery was 25-Feb-2021. On 19-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 30-May-2021, the patient experienced MALAISE (Since having my vaccine I have developed a horrible). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-seventh week of the pregnancy. The delivery occurred  on 29-Jan-2021, which was reported as Full-term. For neonate 1, The outcome was reported as Delivered NOS. On 19-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, MALAISE (Since having my vaccine I have developed a horrible) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2020, Pregnancy test: positive (Positive) Positive. In November 2020, Glucose tolerance test normal: (normal) Normal. In November 2020, Ultrasound abdomen: normal (normal) Normal. In December 2020, Glucose tolerance test normal: (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: Follow-up information received on 31-may-2021. Added a event,Since having my vaccine I have developed a horrible.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patients relevant medical history was not reported. On an unknown date, the patients were vaccinated with subcutaneously with VARIVAX (Merck) (dose, lot# and expiration date were not reported) which had been improperly stored. Information about co-suspect and concomitant medication was not reported. No adverse effect was reported. No PWC (product quality complaint) was involved. Additional information has been requested.
Patient presented to the local community mobile team today. Previously, 43 y/o female has gotten two full doses for Moderna primary series and a Moderna first booster. Today, she attested to being immunocompromised and in database is listed as receiving additional doses (0.5ml) however actually received 0.25ML second booster dose. Since she is immunocompromised it is recommended that she come back to receive an additional 0.25mL dose to equal 0.5mL dose to count as an additional dose
Hard to the touch Injection Site; Red area came back bigger (2 quarter size) Injection Site; Red spot quarter size on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hard to the touch Injection Site), INJECTION SITE ERYTHEMA (Red spot quarter size on the injection site) and VACCINATION SITE ERYTHEMA (Red area came back bigger (2 quarter size) Injection Site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Red spot quarter size on the injection site). On 31-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hard to the touch Injection Site) and VACCINATION SITE ERYTHEMA (Red area came back bigger (2 quarter size) Injection Site). On 24-Jan-2021, INJECTION SITE ERYTHEMA (Red spot quarter size on the injection site) had resolved with sequelae. At the time of the report, VACCINATION SITE INDURATION (Hard to the touch Injection Site) and VACCINATION SITE ERYTHEMA (Red area came back bigger (2 quarter size) Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
MOM came to our clinic on 8/12/08 for the second Gardasil shot. When asked if any problems after the first shot mom reported that after she got home and broke out in hives at the injection site and on her back mom gave Benadryl. Pt also recieved varicella at the same time but had no previous reaction to varicella in the past per mom.
Patient was seen in our office due to increased redness and itching to site vaccine was administered. Vaccine was given at another facility.
HEART PALPITATIONS; HIGH BLOOD PRESSURE; RAPID PULSE; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient was a perfectly healthy athlete at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced heart palpitations, high blood pressure, and rapid pulse. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) High, and Pulse rate (NR: not provided) Rapid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart palpitations, high blood pressure, and rapid pulse. This report was non-serious.
Post vax left thigh became swollen, no redness, no increased warmth and no treatment.
Pain at injection site started approx. 3 hrs after injection, body aches & headache started approx. 5hrs after injection, upset stomach, vomiting 1 time 16hrs after injection. Continued body aches, headache & upset stomach for 24hrs post injection
2nd day after vaccine leg became red, swollen, warm.  Leg was painful and child had difficult walking.  child had fever >102.  Diagnosis: Cellulitis.
Expanding injection site erythema ~10 x 10 cm, warmth, tenderness.
Severe pain at injection site. Severe pain in arm pit of injected arm. Fever. Post nasal drip. Coughing.
Client received vaccines. Approx. 2-3 minutes later, client attempting to stand up, slouched over and slipped to floor. Client aroused few seconds later, alert but light headed.
Patient was very dizzy for about 30 minutes. Lay down in the pharmacy, but did not lose consciousness. Did not want to seek further medical treatment. Left the pharmacy as soon as dizziness went away.
Patient complains of tinnitus in left ear. Exam normal with mild tenderness in ear. Patient referred to ENT.
A non-serious report of Gianotti-Crosti syndrome was received from a literature article concerning an eight-year-old female subsequent to the administration of FLUMIST. The patient had no history of hepatitis, atopy, upper respiratory symptoms, pharyngitis, gastrointestinal symptoms, or fever and chills. Concomitant medications were not reported. On an unknown date, the patient received FLUMIST intranasal. Six weeks later, a persistently pruritic plaque had appeared on the child's abdomen; which was attributed to nicklel dermatitis. Three weeks later, she developed pruritic papules on her face, which spread to her upper chest and upper arms bilaterally. Cephalexin was prescribed by the child's pediatrician for a possible bacterial skin infection. A week later, she was seen at a dermatology clinic for the rash on her face and arms which was worsening. On physical examination, there were excoriated papules and light pink papules about 1-2 mm in size, symmetrically distributed on the forehead, cheeks, chin, upper chest, and extensor surfaces of the arms bilaterally. There also was a well demarcated, pink, scaly plaque above the umbilicus. The diagnosis was thought to be most consistent with Gianotti-Crosti syndrome. Treatment with hydrocortisone 2.5% cream and diphenhydramine were prescribed as needed for pruritus. Two weeks after the initial presentation, the cutaneous findings were almost completely resolved. Rechallenge was not applicable for this product because re-administration of the product was not reported. The reporter assessed that the event could have potentially been related to the administration of FLUMIST. The company assessed the event as possibly related to the administration of FLUMIST.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 28-OCT-2013 the patient was vaccinated with an expired dose of ROTATEQ (Lot# 0283AE, expiration date 24-OCT-2013), dose, frequency and route unspecified. No adverse effects reported. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown date, the unspecified number of patients were vaccinated with GARDASIL (dose, route of administration, lot# and expiration date not reported). The patients received a dose of GARDASIL that was stored improperly, exposed to 34.9F for 4 hours. There was no adverse effects reported. Additional information has been requested. This is one of several reports received from the same reporter.
bi-temporal h/a like a skewer through eyeballs by the time got home p/doing a couple of errands could hardly see straight;laid down & woke up 3hr later-something never does;achy muscles & joints;flu sx;Heberden's nodes;toe red & inflamed;
Patient noticed arm soreness late at night on 12/12/15. Upon waking in the morning on 12/13/15 could not lift arm. A circular rash with swelling, redness, and warmth occurred on the arm vaccine was given but not at the injection site. The reaction became larger throughout the morning but stayed local.
Injecting the vaccine the patent immediately got a superficial hematoma--finished adminstration intramuscularly--applied cold compress and the hematoma reduced in size before leaving the clinic site
Patient falsified DOB when registering for vaccination, stating the minor was 12/08/2015. Guardian consented to the vaccination. Department of Health verified with statistical records that the patients actual DOB is 12/08/2016 which made the vaccine a contraindication.  No known adverse reactions noted.
fever 102-chills- unable to walk-disorientated-loss of appetite-dizzy- we had to take him to his Dr in a wheelchair on Monday ,February the 1st. Doctor put him on covid meds and he is still to this date (Feb. 6th) still weak . we had a covid test done and it was negative.
Pt fell faint. Anxious about vaccine. Did not hurt his head. Landed on his buttocks. No complaint of headache, dizziness, chest pain or shortness of breath. Patient alert, awake, oriented. Vital signs were taken, 11:20 blood pressure 113/82, heart rate 76, spO2 98%.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age. On an unknown date the unspecified number of patients were vaccinated with ZOSTAVAX (dose, lot no. and route not reported). No concomitant medication was reported. On unspecified dates, the patients developed shingles after vaccination. The outcome of shingles was unknown. PQC was not involved. The causality of event with ZOSTAVAX was unknown. Additional information has been requested.
Pt. was given the drug and instructed to wait in the room for 15 mins and stay seated. Mother tried to take the child to waiting room. Pt got to the waiting room where he vomited x2, and started c/o dizziness and malaise. Pt was moved back to a room where he was monitored and released into his mother's care.
She awoke at 2 AM with fever, arm swelling and pain. At 4 AM she went to get Tylenol in other room. I was asleep. Called me for help. She was disoriented and said she didn't feel well. While I was helping her back to bed, she collapsed and had a seizure (non grand mal) for 5 minutes with vomiting and incontinence. She could have hit her head on marble floor if I was not present. Post ictal  she had insomnia, continued arm pain and swelling, and headache.
The night of getting vaccine patient began to experience redness and swelling around the area of the shot. Through the next few days the swelling and redness began to expand in a circular pattern over her shoulder and farther down her upper arm. The patient became concerned about the rash and saw a doctor 6 days later on which she was prescribed Keflex for a possible skin infection to rule it out. The patient is experiencing pain and itchiness and has restricted motion of her arm. The rash appears to have an unaffected circle around the site of the shot about 2 in diameter before the rash starts.